| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) | 
|---|
| 08/22/1995 | US5443983 Developing lymphokine-activated killer activity in population of cultured lymphocytes comprises culturing in medium of interleukin-2 and an antibody to CD3 receptor, removing; now culturing in interleukin-2 medium without antibody | 
| 08/22/1995 | US5443982 Continuous avian hepatocellular carcinoma cell line containing infectious laryngotracheitis virus | 
| 08/22/1995 | US5443968 Fed batch culture method for protein secreting cells | 
| 08/22/1995 | US5443957 Cancer diagnosis | 
| 08/22/1995 | US5443954 Immortalized non-tumorigenic human bronchial epithelial cell lines | 
| 08/22/1995 | US5443950 Implanting in vivo living stromal tissue prepared in vitro, comprising stromal cells with naturally secreted connective tissue proteins attached to and enveloping three-dimensional framework of biocompatible non-living material | 
| 08/22/1995 | US5443827 Chimeric molecule; anticoagulants | 
| 08/22/1995 | US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis | 
| 08/22/1995 | CA2032742C Method of producing brassinosteroids | 
| 08/22/1995 | CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement | 
| 08/17/1995 | WO1995021931A1 Nucleic acid-containing composition, its preparation and use | 
| 08/17/1995 | WO1995021930A2 Method for preparing orphan receptor ligands | 
| 08/17/1995 | WO1995021929A1 Antifungal proteins, dna coding therefor, and hosts incorporating same | 
| 08/17/1995 | WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins | 
| 08/17/1995 | WO1995021923A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor | 
| 08/17/1995 | WO1995021920A1 Hematopoietic protein and materials and methods for making it | 
| 08/17/1995 | WO1995021918A1 Rat osteosarcoma cell lines | 
| 08/17/1995 | WO1995021917A1 Mammalian cell cycle protein | 
| 08/17/1995 | WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells | 
| 08/17/1995 | WO1995021911A1 High performance cell culture bioreactor and method | 
| 08/17/1995 | WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof | 
| 08/17/1995 | WO1995021861A1 Fk-506 cytosolic binding protein | 
| 08/17/1995 | WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality | 
| 08/17/1995 | WO1995021626A1 Methods for stimulating erythropoiesis using thrombopoietin | 
| 08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis | 
| 08/17/1995 | WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells | 
| 08/17/1995 | WO1995007994A3 Recombinant alphavirus vectors | 
| 08/17/1995 | DE4420782C1 New DNA encoding a 2-oxoglutarate-malate translocator | 
| 08/17/1995 | CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof | 
| 08/17/1995 | CA2183266A1 Hematopoietic protein and materials and methods for making it | 
| 08/17/1995 | CA2183254A1 Mammalian cell cycle protein | 
| 08/17/1995 | CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells | 
| 08/17/1995 | CA2182977A1 Inducing tolerance with tolerogenic fusion proteins | 
| 08/17/1995 | CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality | 
| 08/17/1995 | CA2182967A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor | 
| 08/17/1995 | CA2182778A1 Antifungal proteins, dna coding therefor, and hosts incorporating same | 
| 08/17/1995 | CA2182118A1 Nucleic acid-containing composition, its preparation and use | 
| 08/17/1995 | CA2181803A1 Fk-506 cytosolic binding protein | 
| 08/17/1995 | CA2169190A1 Method for preparing orphan receptor ligands | 
| 08/16/1995 | EP0666929A1 Method of inhibiting replication of hyperproliferative cells | 
| 08/16/1995 | EP0666926A1 Nuclear hormone receptor-interacting polypeptides and related molecules and methods | 
| 08/16/1995 | EP0666914A1 Novel p-selectin ligand protein | 
| 08/16/1995 | EP0666911A1 Multidrug resistance gene | 
| 08/16/1995 | EP0666907A1 CULTURE CELLS OF $i(QUILLAJA SP.) | 
| 08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors | 
| 08/16/1995 | EP0666905A1 Molecules with antibody combining sites that induce asymmetry | 
| 08/16/1995 | EP0666902A1 Assessment of bone cell activity | 
| 08/16/1995 | EP0666865A1 Plant fatty acid synthases | 
| 08/16/1995 | EP0578769A4 Immortalization of human endothelial cells | 
| 08/16/1995 | EP0532525B1 New protein-polycation conjugates | 
| 08/16/1995 | EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides | 
| 08/16/1995 | EP0372071B1 Monoclonal antibodies against lens epithelial cells and methods for preventing proliferation of remnant lens epithelial cells after extracapsular extraction | 
| 08/15/1995 | US5442052 Expression of genes in transgenic plants | 
| 08/15/1995 | US5441934 Dna sequences | 
| 08/15/1995 | US5441868 Production of recombinant erythropoietin | 
| 08/10/1995 | WO1995021256A1 Msrv1 virus and msrv2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same | 
| 08/10/1995 | WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof | 
| 08/10/1995 | WO1995021244A1 Monoclonal antibody 88bv59, subclones and method of making | 
| 08/10/1995 | WO1995021178A1 Nucleic acid transfection efficiency increase by use of isopropanol in aqueous solutions | 
| 08/10/1995 | WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides | 
| 08/10/1995 | WO1995020872A1 Genetic engineering of mollusks | 
| 08/10/1995 | CA2182501A1 Genetic engineering of mollusks | 
| 08/10/1995 | CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides | 
| 08/10/1995 | CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof | 
| 08/10/1995 | CA2158572A1 Monoclonal antibody 88bv59, subclones and method of making | 
| 08/09/1995 | EP0665888A1 Ryegrass pollen allergen | 
| 08/09/1995 | EP0665887A1 Human 5-ht 2? receptor | 
| 08/09/1995 | EP0665886A1 Cyclin complex rearrangement and uses related thereto | 
| 08/09/1995 | EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof | 
| 08/09/1995 | EP0656883A4 Cationic lipids. | 
| 08/09/1995 | EP0535007B1 A MONOCLONAL ANTIBODY AGAINST THE GAG PROTEIN PRECURSOR p55 OF HUMAN IMMUNODEFICIENCY VIRUS | 
| 08/09/1995 | CN1106461A Method for prepn. of colony stimulating factor | 
| 08/08/1995 | US5439820 Anti-thrombin polypeptides | 
| 08/08/1995 | US5439807 Methods for the preparation of endotoxin-binding proteins | 
| 08/08/1995 | US5439795 Cystine residue linked to glycine residue at the end of carboxy terminus of peptide; animal growth regulator | 
| 08/08/1995 | US5439679 Peptide plasminogen activators | 
| 08/05/1995 | CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications | 
| 08/03/1995 | WO1995020678A1 Human dna mismatch repair proteins | 
| 08/03/1995 | WO1995020675A1 Method for separating rare cells from a population of cells | 
| 08/03/1995 | WO1995020672A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies | 
| 08/03/1995 | WO1995020671A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof | 
| 08/03/1995 | WO1995020661A1 Materials and methods for management of hyperacute rejection in human xenotransplantation | 
| 08/03/1995 | WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene | 
| 08/03/1995 | WO1995020654A1 Folding proteins | 
| 08/03/1995 | WO1995020651A1 Protein modifying enzyme | 
| 08/03/1995 | WO1995020649A1 Ex vivo activation of immune cells | 
| 08/03/1995 | WO1995020605A1 Immuno-stimulatory monoclonal antibodies | 
| 08/03/1995 | WO1995020429A1 Density gradient medium for separating cells | 
| 08/03/1995 | WO1995020318A1 Ancient organisms | 
| 08/03/1995 | WO1995017508A3 Glutamate receptor (or eaa receptor) polynucleotides and their uses | 
| 08/03/1995 | WO1995012660A3 Recombinant p53 adenovirus methods and compositions | 
| 08/03/1995 | CA2182499A1 Folding proteins | 
| 08/03/1995 | CA2182380A1 Recombinant baculovirus and use thereof in the production of monoclonal antibodies | 
| 08/03/1995 | CA2182269A1 Ancient organisms | 
| 08/03/1995 | CA2182206A1 Human dna mismatch repair proteins | 
| 08/03/1995 | CA2181602A1 Method for preparing recombinant adeno-associated viruses (aav), and uses thereof | 
| 08/03/1995 | CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene | 
| 08/02/1995 | EP0665290A2 Process for gene transfer into plant cells | 
| 08/02/1995 | EP0665289A2 Peptides from GAD65, provoking autoimmune reactions | 
| 08/02/1995 | EP0664834A1 Recombinant humanized anti-cytomegalovirus antibodies |